XML 92 R78.htm IDEA: XBRL DOCUMENT
v3.23.2

Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details) - EUR (€) € in Millions | 6 Months Ended |
--- | --- | ---
Jun. 30, 2023 | Dec. 31, 2022
Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward] |  |
Beginning balance | € 779 |
Payments made | (88) |
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) | 36 |
Currency translation differences | (10) |
Ending balance | 717 |
Current portion | 154 | € 105
Non-current portion | 563 | € 674
Bayer contingent consideration arising from acquisition of Genzyme |  |
Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward] |  |
Beginning balance | 26 |
Payments made | (11) |
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) | (2) |
Currency translation differences | 0 |
Ending balance | 13 |
MSD contingent consideration (European Vaccines business) |  |
Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward] |  |
Beginning balance | 204 |
Payments made | (77) |
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) | 6 |
Currency translation differences | 0 |
Ending balance | 133 |
Shire contingent consideration arising from acquisition of Translate Bio |  |
Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward] |  |
Beginning balance | 380 |
Payments made | 0 |
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) | 15 |
Currency translation differences | (6) |
Ending balance | 389 |
Contingent consideration arising from acquisition of Amunix |  |
Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward] |  |
Beginning balance | 165 |
Payments made | 0 |
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) | 17 |
Currency translation differences | (4) |
Ending balance | 178 |
Other |  |
Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward] |  |
Beginning balance | 4 |
Payments made | 0 |
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) | 0 |
Currency translation differences | 0 |
Ending balance | € 4 |

X
- Definition The amount of contingent liabilities recognised in a business combination. [Refer: Contingent liabilities [member]; Business combinations [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2022-03-24 -Paragraph B67 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B -URIDate 2022-03-24 + Details
Name: | ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The gains (losses) including exchange differences recognised in profit or loss on the fair value measurement of liabilities. [Refer: At fair value [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2022-03-24 -Paragraph 93 -Subparagraph e -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2022-en-r&anchor=para_93_e_i&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of contingent liabilities recognised in a business combination that were settled. [Refer: Contingent liabilities recognised in business combination] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 3 -IssueDate 2022-03-24 -Paragraph B67 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2022-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B -URIDate 2022-03-24 + Details
Name: | ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward] + References No definition available. + Details
Name: | sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward
Namespace Prefix: | sny_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests. + References No definition available. + Details
Name: | sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Increase decrease through net exchange differences business combinations and noncontrolling interests. + References No definition available. + Details
Name: | sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests. + References No definition available. + Details
Name: | sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
Namespace Prefix: | sny_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=sny_BayerContingentPurchaseConsiderationArisingFromAcquisitionOfGenzymeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=sny_ContingentConsiderationArisingFromAcquisitionOfAmunixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_BusinessCombinationsAxis=sny_OtherLiabilities1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |